article 3 months old

ReAc Returns But Merrill Lynch Just Isn’t Interested

Australia | Jul 06 2006

Array
(
    [0] => Array
        (
        )

    [1] => Array
        (
        )

)
List StockArray ( )

By Greg Peel

Calliden Group (CIX) is a start-up insurer risen from the ashes of ReAc or at least the capital from the ReAc run-off. Merrill Lynch analysts met with management and had a good look at the 2004 and 2005 books.

The result is thanks but no thanks – Merrills has reported that it will not be covering the stock because it is not convinced profitability is ensured. Too hard to value, lack of underwriting track record, top of the insurance cycle. Merrills has given this one a wide berth for now.

To share this story on social media platforms, click on the symbols below.

Click to view our Glossary of Financial Terms

Australian investors stay informed with FNArena – your trusted source for Australian financial news. We deliver expert analysis, daily updates on the ASX and commodity markets, and deep insights into companies on the ASX200 and ASX300, and beyond. Whether you're seeking a reliable financial newsletter or comprehensive finance news and detailed insights, FNArena offers unmatched coverage of the stock market news that matters. As a leading financial online newspaper, we help you stay ahead in the fast-moving world of Australian finance news.